Additionally, the expression of ITGB1 and TNF in the disease group was significantly higher than that in the control group, and TNF, as a key indicator of inflammation, was closely related to COVID‐19.[13] Thus, TNF may be the key targets of GanCao─GeGen in the treatment of COVID‐19. This evidence concerns the gene ITGB1 and COVID-19.